FindTrial
Sign In

Nature course and predictors of progression of intramural hematoma: A retrospective, multicenter study

Nature course and predictors of progression of intramural hematoma: A retrospective, multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073829
Enrollment
Unknown
Registered
2023-07-21
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intramural hematoma

Interventions

IMH steady:NA
IMH progression:NA

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Male or female = 18 years old; 2) The CTA results clearly diagnosed IMH; 3) At least one CTA follow-up.

Exclusion criteria

Exclusion criteria: 1) Type A dissection, patients undergoing open surgery; 2) Patients with a life expectancy of less than 1 year.

Design outcomes

Primary

MeasureTime frame
all-cause mortality;aorta-related mortality;—

Countries

China

Contacts

Public ContactZhihui Dong

Zhongshan Hospital, Fudan University

dzh926@126.com+86 135 6424 9168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026